Central Nervous System Device Infections

Infectious Disease Clinics of North America

Volumn 26, Issue 1, 2012, Pages 89-110

  Stenehjem, Edward ^a   Armstrong, Wendy S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deep brain stimulator; Infection; Meningitis; Ventriculitis; Ventriculostomy

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; COLISTIN; DAPTOMYCIN; ECHINOCANDIN; FLUCONAZOLE; GENTAMICIN; ITRACONAZOLE; LINEZOLID; MINOCYCLINE; NAFCILLIN; POLYMYXIN B; RIFAMPICIN; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN; VORICONAZOLE;

ACINETOBACTER INFECTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARACHNOIDITIS; ASEPSIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID DRAINAGE; CLINICAL EFFECTIVENESS; DEVICE INFECTION; DEVICE REMOVAL; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENTEROCOCCAL INFECTION; EXTRAINTRACRANIAL ANASTOMOSIS; GRAM NEGATIVE INFECTION; HEADACHE; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIQUORRHEA; MATERIAL COATING; MEDICAL INSTRUMENTATION; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGY; NONHUMAN; POSTOPERATIVE INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SHUNT INFECTION; STAPHYLOCOCCUS INFECTION; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT PLANNING; VOMITING;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CATHETER-RELATED INFECTIONS; CENTRAL NERVOUS SYSTEM DISEASES; DEEP BRAIN STIMULATION; HUMANS; MYCOSES; PROSTHESES AND IMPLANTS; RISK FACTORS; VENTRICULOSTOMY;

EID: 84856255612     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2011.09.006     Document Type: Review

References (97)

1. Dandy W.E. An operative procedure for hydrocephalus. Bull Johns Hopkins Hosp 1922, 33:189-190.
2. Lozier A.P., Sciacca R.R., Romagnoli M.F., et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 2002, 51(1):170-181.
3. Sundbarg G., Nordstrom C.H., Soderstrom S. Complications due to prolonged ventricular fluid pressure recording. Br J Neurosurg 1988, 2(4):485-495.
4. Holloway K.L., Barnes T., Choi S., et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. JNeurosurg 1996, 85(3):419-424.
5. Mayhall C.G., Archer N.H., Lamb V.A., et al. Ventriculostomy-related infections. A prospective epidemiologic study. NEngl J Med 1984, 310(9):553-559.
6. Hoefnagel D., Dammers R., Ter Laak-Poort M.P., et al. Risk factors for infections related to external ventricular drainage. Acta Neurochir (Wien) 2008, 150(3):209-214.
7. Tse T., Cheng K., Wong K., et al. Ventriculostomy and infection: a 4-year-review in a local hospital. Surg Neurol Int 2010, 1:47.
8. Chi H., Chang K.Y., Chang H.C., et al. Infections associated with indwelling ventriculostomy catheters in a teaching hospital. Int J Infect Dis 2010, 14(3):e216-e219.
9. Schade R.P., Schinkel J., Visser L.G., et al. Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. JNeurosurg 2005, 102(2):229-234.
10. Korinek A.M., Reina M., Boch A.L., et al. Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien) 2005, 147(1):39-45.
11. Lo C.H., Spelman D., Bailey M., et al. External ventricular drain infections are independent of drain duration: an argument against elective revision. JNeurosurg 2007, 106(3):378-383.
12. Lyke K.E., Obasanjo O.O., Williams M.A., et al. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis 2001, 33(12):2028-2033.
13. Pfisterer W., Muhlbauer M., Czech T., et al. Early diagnosis of external ventricular drainage infection: results of a prospective study. JNeurol Neurosurg Psychiatry 2003, 74(7):929-932.
14. Scheithauer S., Burgel U., Bickenbach J., et al. External ventricular and lumbar drainage-associated meningoventriculitis: prospective analysis of time-dependent infection rates and risk factor analysis. Infection 2010, 38(3):205-209.
15. Scheithauer S., Burgel U., Ryang Y.M., et al. Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit. JNeurol Neurosurg Psychiatry 2009, 80(12):1381-1385.
16. Wong G.K., Poon W.S., Wai S., et al. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial. JNeurol Neurosurg Psychiatry 2002, 73(6):759-761.
17. Winfield J.A., Rosenthal P., Kanter R.K., et al. Duration of intracranial pressure monitoring does not predict daily risk of infectious complications. Neurosurgery 1993, 33(3):424-430.
18. Arabi Y., Memish Z.A., Balkhy H.H., et al. Ventriculostomy-associated infections: incidence and risk factors. Am J Infect Control 2005, 33(3):137-143.
19. Federico G., Tumbarello M., Spanu T., et al. Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. Scand J Infect Dis 2001, 33(7):533-537.
20. Camacho E.F., Boszczowski I., Basso M., et al. Infection rate and risk factors associated with infections related to external ventricular drain. Infection 2011, 39(1):47-51.
21. Flibotte J.J., Lee K.E., Koroshetz W.J., et al. Continuous antibiotic prophylaxis and cerebral spinal fluid infection in patients with intracranial pressure monitors. Neurocrit Care 2004, 1(1):61-68.
22. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36(5):309-332.
23. Vincent F.M. Hypoglycorrhachia after subarachnoid hemorrhage. Neurosurgery 1981, 8(1):7-14.
24. Ross D., Rosegay H., Pons V. Differentiation of aseptic and bacterial meningitis in postoperative neurosurgical patients. JNeurosurg 1988, 69(5):669-674.
25. Muttaiyah S., Ritchie S., Upton A., et al. Clinical parameters do not predict infection in patients with external ventricular drains: a retrospective observational study of daily cerebrospinal fluid analysis. JMed Microbiol 2008, 57(Pt 2):207-209.
26. Schade R.P., Schinkel J., Roelandse F.W., et al. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. JNeurosurg 2006, 104(1):101-108.
27. Pfausler B., Beer R., Engelhardt K., et al. Cell index-a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage?. Acta Neurochir (Wien) 2004, 146(5):477-481.
28. Martinez R., Gaul C., Buchfelder M., et al. Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients. Intensive Care Med 2002, 28(2):208-210.
29. Berger C., Schwarz S., Schaebitz W.R., et al. Serum procalcitonin in cerebral ventriculitis. Crit Care Med 2002, 30(8):1778-1781.
30. Wong G.K., Poon W.S., Ip M. Use of ventricular cerebrospinal fluid lactate measurement to diagnose cerebrospinal fluid infection in patients with intraventricular haemorrhage. JClin Neurosci 2008, 15(6):654-655.
31. Deutch S., Dahlberg D., Hedegaard J., et al. Diagnosis of ventricular drainage-related bacterial meningitis by broad-range real-time polymerase chain reaction. Neurosurgery 2007, 61(2):306-311.
32. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118(1):146-155.
33. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34(6):1589-1596.
34. Marchaim D., Gottesman T., Schwartz O., et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2010, 54(12):5099-5104.
35. Pfausler B., Spiss H., Beer R., et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. JNeurosurg 2003, 98(5):1040-1044.
36. Beer R., Engelhardt K.W., Pfausler B., et al. Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother 2007, 51(1):379-382.
37. Myrianthefs P., Markantonis S.L., Vlachos K., et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006, 50(12):3971-3976.
38. Villani P., Regazzi M.B., Marubbi F., et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 2002, 46(3):936-937.
39. Rupprecht T.A., Pfister H.W. Clinical experience with linezolid for the treatment of central nervous system infections. Eur J Neurol 2005, 12(7):536-542.
40. Viale P., Pagani L., Cristini F., et al. Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 2002, 34(6):456-459.
41. Boak L.M., Li J., Spelman D., et al. Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis. Ann Pharmacother 2006, 40(7-8):1451-1455.
42. Ntziora F., Falagas M.E. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007, 41(2):296-308.
43. Kethireddy S., Andes D. CNS pharmacokinetics of antifungal agents. Expert Opin Drug Metab Toxicol 2007, 3(4):573-581.
44. Tangden T., Enblad P., Ullberg M., et al. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011, 52(11):1310-1316.
45. Elvy J., Porter D., Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. JAntimicrob Chemother 2008, 61(2):461-462.
46. Kim B.N., Peleg A.Y., Lodise T.P., et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009, 9(4):245-255.
47. Lopez-Alvarez B., Martin-Laez R., Farinas M.C., et al. Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir (Wien) 2009, 151(11):1465-1472.
48. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39(9):1267-1284.
49. Mathisen G., Shelub A., Truong J., et al. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore) 2010, 89(5):251-284.
50. Ziai W.C., Lewin J.J. Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol 2009, 22(3):277-282.
51. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7(10):645-657.
52. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49(1):1-45.
53. Resar R., Pronovost P., Haraden C., et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005, 31(5):243-248.
54. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. NEngl J Med 2006, 355(26):2725-2732.
55. Guerin K., Wagner J., Rains K., et al. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 2010, 38(6):430-433.
56. Leverstein-van Hall M.A., Hopmans T.E., van der Sprenkel J.W., et al. Abundle approach to reduce the incidence of external ventricular and lumbar drain-related infections. JNeurosurg 2010, 112(2):345-353.
57. Honda H., Jones J.C., Craighead M.C., et al. Reducing the incidence of intraventricular catheter-related ventriculitis in the neurology-neurosurgical intensive care unit at a tertiary care center in St Louis, Missouri: an 8-year follow-up study. Infect Control Hosp Epidemiol 2010, 31(10):1078-1081.
58. Sonabend A.M., Korenfeld Y., Crisman C., et al. Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review. Neurosurgery 2011, 68(4):996-1005.
59. Alleyne C.H., Hassan M., Zabramski J.M. The efficacy and cost of prophylactic and periprocedural antibiotics in patients with external ventricular drains. Neurosurgery 2000, 47(5):1124-1127.
60. Poon W.S., Ng S., Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl 1998, 71:146-148.
61. Ramos E.R., Reitzel R., Jiang Y., et al. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 2011, 39(2):245-251.
62. Zabramski J.M., Whiting D., Darouiche R.O., et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. JNeurosurg 2003, 98(4):725-730.
63. Muttaiyah S., Ritchie S., John S., et al. Efficacy of antibiotic-impregnated external ventricular drain catheters. JClin Neurosci 2010, 17(3):296-298.
64. Tamburrini G., Massimi L., Caldarelli M., et al. Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien) 2008, 150(10):1049-1055.
65. Gutierrez-Gonzalez R., Boto G.R., Fernandez-Perez C., et al. Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures. BMC Neurol 2010, 10:93.
66. Abla A.A., Zabramski J.M., Jahnke H.K., et al. Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial. Neurosurgery 2011, 68(2):437-442.
67. Harrop J.S., Sharan A.D., Ratliff J., et al. Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery 2010, 67(1):187-191.
68. Stevens E.A., Palavecino E., Sherertz R.J., et al. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an invitro analysis. JNeurosurg 2010, 113(1):86-92.
69. Aslam S., Darouiche R.O. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters. JAntimicrob Chemother 2007, 60(1):148-151.
70. Wang H., Huang T., Jing J., et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. JHosp Infect 2010, 76(1):1-11.
71. Srinivasan A., Karchmer T., Richards A., et al. Aprospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 2006, 27(1):38-43.
72. Fichtner J., Guresir E., Seifert V., et al. Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis. JNeurosurg 2010, 112(4):840-846.
73. Korinek A.M., Fulla-Oller L., Boch A.L., et al. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults an 8-year study. Neurosurgery 2011, 68(4):985-994.
74. Conen A., Walti L.N., Merlo A., et al. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin Infect Dis 2008, 47(1):73-82.
75. Whitehead W.E., Kestle J.R. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 2001, 35(4):205-210.
76. Benabid A.L., Pollak P., Louveau A., et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987, 50(1-6):344-346.
77. Gorgulho A., Juillard C., Uslan D.Z., et al. Infection following deep brain stimulator implantation performed in the conventional versus magnetic resonance imaging-equipped operating room. JNeurosurg 2009, 110(2):239-246.
78. Sillay K.A., Larson P.S., Starr P.A. Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery 2008, 62(2):360-366.
79. Fily F., Haegelen C., Tattevin P., et al. Deep brain stimulation hardware-related infections: a report of 12 cases and review of the literature. Clin Infect Dis 2011, 52(8):1020-1023.
80. Oh M.Y., Abosch A., Kim S.H., et al. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002, 50(6):1268-1274.
81. Vergani F., Landi A., Pirillo D., et al. Surgical, medical, and hardware adverse events in a series of 141 patients undergoing subthalamic deep brain stimulation for Parkinson disease. World Neurosurg 2010, 73(4):338-344.
82. Voges J., Waerzeggers Y., Maarouf M., et al. Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery-experiences from a single centre. JNeurol Neurosurg Psychiatry 2006, 77(7):868-872.
83. Lanotte M., Verna G., Panciani P.P., et al. Management of skin erosion following deep brain stimulation. Neurosurg Rev 2009, 32(1):111-114.
84. Spiotta A.M., Bain M.D., Deogaonkar M., et al. Methods of scalp revision for deep brain stimulator hardware: case report. Neurosurgery 2008, 62(3 Suppl 1):249-250.
85. Anderson D.J., Kaye K.S., Classen D., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S51-S61.
86. Orsi G.B., Scorzolini L., Franchi C., et al. Hospital-acquired infection surveillance in a neurosurgical intensive care unit. JHosp Infect 2006, 64(1):23-29.
87. Bota D.P., Lefranc F., Vilallobos H.R., et al. Ventriculostomy-related infections in critically ill patients: a 6-year experience. JNeurosurg 2005, 103(3):468-472.
88. Doshi P.K. Long-term surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 2011, 89(2):89-95.
89. Hu X., Jiang X., Zhou X., et al. Avoidance and management of surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 2010, 88(5):296-303.
90. Follett K.A., Weaver F.M., Stern M., et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. NEngl J Med 2010, 362(22):2077-2091.
91. Seijo F.J., Alvarez-Vega M.A., Gutierrez J.C., et al. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures. Acta Neurochir (Wien) 2007, 149(9):867-875.
92. Blomstedt P., Hariz M.I. Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochir (Wien) 2005, 147(10):1061-1064.
93. Lyons K.E., Wilkinson S.B., Overman J., et al. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 2004, 63(4):612-616.
94. Umemura A., Jaggi J.L., Hurtig H.I., et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. JNeurosurg 2003, 98(4):779-784.
95. Joint C., Nandi D., Parkin S., et al. Hardware-related problems of deep brain stimulation. Mov Disord 2002, 17(Suppl 3):S175-S180.
96. Beric A., Kelly P.J., Rezai A., et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001, 77(1-4):73-78.
97. Temel Y., Ackermans L., Celik H., et al. Management of hardware infections following deep brain stimulation. Acta Neurochir (Wien) 2004, 146(4):355-361.